Nitazene Response Act: New Guidelines for Opioid Overdoses
This bill is currently sitting in the House Committee on Energy and Commerce. No action has been taken on the proposal since April 1, 2026, which means it has been stalled for three months. The committee members must decide whether to hold a vote on the bill before it can move any further.
While drug safety is often a bipartisan issue, most bills introduced by a single member without a large group of supporters fail to move past the committee stage.
Govbase has not yet run an impact analysis on this legislation.
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Nitazene Response Act
Analysis generated by AI. Always verify with official sources.